DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications
- PMID: 23859405
- DOI: 10.1111/ejh.12169
DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications
Abstract
Interstrand cross-links (ICLs) are extremely toxic DNA lesions that prevent DNA double-helix separation due to the irreversible covalent linkage binding of some agents on DNA strands. Agents that induce these ICLs are thus widely used as chemotherapeutic drugs but may also lead to tumor growth. Fanconi anemia (FA) is a rare genetic disorder that leads to ICL sensitivity. This review provides update on current understanding of the role of FA proteins in repairing ICLs at various stages of cell cycle. We also discuss link between DNA cross-link genotoxicity caused by aldehydes in FA pathway. Besides this, we summarize various ICL agents that act as drugs to treat different types of tumors and highlight strategies for modulating ICL sensitivity for therapeutic interventions that may be helpful in controlling cancer and life-threatening disease, FA.
Keywords: Fanconi anemia; cancer; chemotherapy; interstrand cross-links.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Fanconi anemia pathway--the way of DNA interstrand cross-link repair.Pharmazie. 2013 Jan;68(1):5-11. Pharmazie. 2013. PMID: 23444773 Review.
-
The Fanconi anemia pathway and DNA interstrand cross-link repair.Protein Cell. 2011 Sep;2(9):704-11. doi: 10.1007/s13238-011-1098-y. Epub 2011 Sep 23. Protein Cell. 2011. PMID: 21948210 Free PMC article. Review.
-
The Fanconi anemia pathway in replication stress and DNA crosslink repair.Cell Mol Life Sci. 2012 Dec;69(23):3963-74. doi: 10.1007/s00018-012-1051-0. Epub 2012 Jun 29. Cell Mol Life Sci. 2012. PMID: 22744751 Free PMC article. Review.
-
C. elegans: a model of Fanconi anemia and ICL repair.Mutat Res. 2009 Jul 31;668(1-2):103-16. doi: 10.1016/j.mrfmmm.2008.11.007. Epub 2008 Nov 19. Mutat Res. 2009. PMID: 19059419 Review.
-
Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.DNA Repair (Amst). 2007 Nov;6(11):1670-8. doi: 10.1016/j.dnarep.2007.06.002. Epub 2007 Jul 31. DNA Repair (Amst). 2007. PMID: 17669695 Free PMC article.
Cited by
-
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.Br J Cancer. 2022 Nov;127(9):1615-1628. doi: 10.1038/s41416-022-01946-9. Epub 2022 Aug 23. Br J Cancer. 2022. PMID: 35999268 Free PMC article.
-
Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.Tumour Biol. 2015 May;36(5):3591-9. doi: 10.1007/s13277-014-2996-4. Epub 2014 Dec 27. Tumour Biol. 2015. PMID: 25542235
-
High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2.PLoS Pathog. 2019 Feb 28;15(2):e1007442. doi: 10.1371/journal.ppat.1007442. eCollection 2019 Feb. PLoS Pathog. 2019. PMID: 30818369 Free PMC article.
-
FANCI is a negative regulator of Akt activation.Cell Cycle. 2016;15(8):1134-43. doi: 10.1080/15384101.2016.1158375. Cell Cycle. 2016. PMID: 27097374 Free PMC article.
-
Towards Personalized Management of Ovarian Cancer.Cancer Manag Res. 2022 Dec 15;14:3469-3483. doi: 10.2147/CMAR.S366681. eCollection 2022. Cancer Manag Res. 2022. PMID: 36545222 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources